CIK 0000728387
- Non-accelerated filer
- Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411458152
- Phone
- +1 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 26,676 shares at an average $2.24 ($59,673)
- 4 Open-market buy Director bought 60,337 shares at an average $2.19 ($132,151)
- 4 Open-market buy Chief Financial Officer bought 33,333 shares at $2.25 ($74,946)
- 4 Open-market buy Director bought 23,475 shares at $2.13 ($49,999)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 25,975 shares at $3.85 ($100,004)
- 4 Open-market buy CEO bought 8,000 shares at $3.77 ($30,132)
- 4/A Insider Changes in Ownership
Page 2 of 17 · 338 filings